- This just in July 30
Pharmaceutical giant Pfizer Inc. agreed Wednesday to buy the vaccines unit of Baxter International Inc. in a $635 million deal, Reuters reports.
Through the acquisition, Pfizer will have access to Baxter's meningitis vaccine and its encephalitis vaccine, both of which are currently available outside of the United States. Pfizer will also gain access to part of Baxter's vaccine production facility in Austria.
Pfizer's global vaccines business reported sales of $1.1 billion in the second quarter, while Baxter's international vaccines sales totaled $110 million in the same timeframe. The deal is expected to close by the end of the year.- -
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- After Ferguson: Stop deferring to the cops
- Ferguson riots were terrible — but this racist reaction was worse
- The hilarious hypocrisy of Republicans complaining about the imperial presidency
- Don't argue about politics this Thanksgiving. Just don't.
- Is it now OK to have sex with animals?
- 7 grammar rules you really should pay attention to
- 43 TV shows to watch in 2014
- In Ferguson, Michael Brown lost his life — and America's police lost the benefit of the doubt
- How to be the most productive person in your office — and still get home by 5:30 p.m.
- 10 things you need to know today: November 26, 2014
Subscribe to the Week